Heather Wakelee

Heather Wakelee is a leading thoracic oncologist who has participated in pivotal clinical trials transforming lung cancer treatment. She was a key investigator on the IMpower133 trial that established atezolizumab plus chemotherapy as first-line standard of care for extensive-stage SCLC. She has contributed to multiple national cooperative group SCLC trials and leads translational research programs in thoracic oncology. Her clinical research spans SCLC, NSCLC, and rare thoracic malignancies with extensive contributions to advancing immunotherapy in lung cancer.